Stocks · News reference

EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades

Sep 3, 2026, 11:33 AMVandana Singh

Modular Medical receives FDA clearance for software enhancements to its Pivot insulin delivery system ahead of its planned Q4 launch.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARSep 29, 2026, 8:10 PMSEC EDGAR
8-K filing — Modular Medical, Inc. (MODD)
Filed: 2026-09-29 AccNo: 0001213900-26-104656 Size: 186 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
MODD
BenzingaSep 4, 2026, 3:13 PMVandana Singh
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Modular Medical secured a national PBM contract to expand access to its Pivot tubeless insulin patch pump for patients managing diabetes.
MODD
BenzingaSep 4, 2026, 12:04 PMBenzinga Newsdesk
Modular Medical Receives Contract From Undisclosed U.S. Pharmacy Benefit Manager To Provide Its Insulin Delivery System
Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump,
MODD
BenzingaSep 3, 2026, 12:03 PMBenzinga Newsdesk
Modular Medical Says FDA Cleared Software Enhancements To Pivot Tubeless Patch Pump, Including Bolus Dosing Customization And User-Interface Upgrades, Ahead Of Planned Q4 Launch
MODD